PURPOSE: To compare performance of two computer-aided detection (CAD) systems and an in-house scheme applied to five groups of sequentially acquired screening mammograms. MATERIALS AND METHODS: Two hundred nineteen film-based mammographic examinations, classified into five groups, were included in this study. Group 1 included 58 examinations in which verified malignant masses were detected during screening; group 2, 39 in which all available latest examinations were performed prior to diagnosis of these malignant masses (subset of 39 women from group 1); group 3, 22 in which findings were interpreted as negative but were verified as cancer within 1 year from the negative interpretation (missed cancers); group 4, 50 in which findings were negative and patients were not recalled for additional procedures; and group 5, 50 in which patients were recalled for additional procedures and findings were negative for cancer. In all examinations, images were processed with two Food and Drug Administration-approved commercially available CAD systems and an in-house scheme. Performance levels in terms of true-positive detection rates and number of false-positive identifications per image and per examination were compared. RESULTS: Mass detection rates in positive examinations (group 1) were 67%-72%. Detection rates among three systems were not significantly different (P > .05). In 50 negative screening examinations (group 4), false-positive rates ranged from 1.08 to 1.68 per four-view examination. Performance level differences among systems were significant for false-positive rates (P = .008). Performance of all systems was at levels lower than publicly suggested in some retrospective studies. False-positive CAD cueing rates were significantly higher for negative examinations in which patients were recalled (group 5) than they were for those in which patients were not recalled (group 4) (P < or = .002). CONCLUSION: Performance of CAD systems for mass detection at mammography varies significantly, depending on examination and system used. Actual performance of all systems in clinical environment can be improved.
PURPOSE: To compare performance of two computer-aided detection (CAD) systems and an in-house scheme applied to five groups of sequentially acquired screening mammograms. MATERIALS AND METHODS: Two hundred nineteen film-based mammographic examinations, classified into five groups, were included in this study. Group 1 included 58 examinations in which verified malignant masses were detected during screening; group 2, 39 in which all available latest examinations were performed prior to diagnosis of these malignant masses (subset of 39 women from group 1); group 3, 22 in which findings were interpreted as negative but were verified as cancer within 1 year from the negative interpretation (missed cancers); group 4, 50 in which findings were negative and patients were not recalled for additional procedures; and group 5, 50 in which patients were recalled for additional procedures and findings were negative for cancer. In all examinations, images were processed with two Food and Drug Administration-approved commercially available CAD systems and an in-house scheme. Performance levels in terms of true-positive detection rates and number of false-positive identifications per image and per examination were compared. RESULTS: Mass detection rates in positive examinations (group 1) were 67%-72%. Detection rates among three systems were not significantly different (P > .05). In 50 negative screening examinations (group 4), false-positive rates ranged from 1.08 to 1.68 per four-view examination. Performance level differences among systems were significant for false-positive rates (P = .008). Performance of all systems was at levels lower than publicly suggested in some retrospective studies. False-positive CAD cueing rates were significantly higher for negative examinations in which patients were recalled (group 5) than they were for those in which patients were not recalled (group 4) (P < or = .002). CONCLUSION: Performance of CAD systems for mass detection at mammography varies significantly, depending on examination and system used. Actual performance of all systems in clinical environment can be improved.
Authors: Jun Wei; Berkman Sahiner; Lubomir M Hadjiiski; Heang-Ping Chan; Nicholas Petrick; Mark A Helvie; Marilyn A Roubidoux; Jun Ge; Chuan Zhou Journal: Med Phys Date: 2005-09 Impact factor: 4.071
Authors: Jun Wei; Heang-Ping Chan; Berkman Sahiner; Lubomir M Hadjiiski; Mark A Helvie; Marilyn A Roubidoux; Chuan Zhou; Jun Ge Journal: Med Phys Date: 2006-11 Impact factor: 4.071
Authors: Bin Zheng; Claudia Mello-Thoms; Xiao-Hui Wang; Gordon S Abrams; Jules H Sumkin; Denise M Chough; Marie A Ganott; Amy Lu; David Gur Journal: Acad Radiol Date: 2007-08 Impact factor: 3.173